Law firm or agent

ASTRAZENECA MEDIMMUNE

Save Like

1,118 applicationsfiled 2006 to 2026

Allowance rate

50%

−26 pts vs the USPTO range 46% to 53%

Rejections before allowance

1.1

−0.5 vs the USPTO

Months to first action

18.6 mo

level with the USPTO

Needed an RCE

14%

−13 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds456 apps

A61K Medical preparations349 apps

C07K Peptides153 apps

A61P Therapeutic activity of compounds49 apps

C12N Microorganisms or enzymes34 apps

C07C 14 apps

Art units

1624188 apps

1626133 apps

1625105 apps

164350 apps

OPAP48 apps

162242 apps

Examiners met

The examiners seen most, and how it went with each

Docket Central48 apps

n/a

Rebecca L Anderson28 apps

71%

Kahsay Habte24 apps

63%

Douglas M Willis23 apps

57%

Deepak R Rao22 apps

27%

Brian E McDowell21 apps

57%

Shawquia Jackson20 apps

70%

Golam M Shameem19 apps

72%

Bars show the share of decided applications that were allowed.

Unlock the examiners this firm meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who they file for

Clients with the most applications

ASTRAZENECA AB628 apps

50%

MEDIMMUNE LIMITED213 apps

47%

Ionis Pharmaceuticals, Inc.19 apps

60%

ASTRAZENECA UK LIMITED18 apps

25%

ARDEA BIOSCIENCES, INC.17 apps

94%

Hoffmann-La Roche Inc.15 apps

100%

Medlmmune Limited10 apps

44%

Hutchison Medipharma Limited9 apps

89%

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19623988	MODIFIED ARENAVIRUS PARTICLES EXPRESSING CANCER TESTIS ANTIGENS AS CANCER IMMUNOTHE…	2026-09-14	Pending	0	0	n/a
19623270	PCSK9 INHIBITORS AND METHODS OF USE THEREOF	2026-09-11	Pending	0	0	n/a
19623254	PCSK9 INHIBITORS AND METHODS OF USE THEREOF	2026-09-11	Pending	0	0	n/a
15971910	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15354620	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15842268	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15369979	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15876975	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15223486	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15972585	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 1,118 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in